Abstract
Objective: The objective of this study was to synthesize a series of 1,3,4-thiadiazole derivative and evaluate their possible in vitro and in vivo anticancer activity.
Method: Compounds 7a-f have been synthesized by chlorination of 2-[bis(2-hydroxyethyl)amino]-N-[5- substituted phenyl)-1,3,4-thiadiazol-2-yl]acetohydrazide with phosphorous oxychloride and phosphorous pentachloride. Synthesis of the targeted compounds was (7a-f) confirmed through their MP, IR, 1HNMR and mass spectrum studies.
Results: Compounds 7a and 7d showed considerable anticancer activity against Hep-2 cell lines and, therefore, selected for the in vitro studies and DLA cell line for the in vivo studies.
Conclusion: It may be concluded that the presence of nitro and chloro phenyl substituted 1,3,4- thiadiazoles showed significant anticancer activity.
Keywords: Anticancer activity, 1, 3, 4-thiadiazole, daltons lymphoma ascites (DLA) cell line, 5-flurouracil, in vitro and in vivo screening.
Current Bioactive Compounds
Title:Synthesis of 2-(Bis (2-Chloroethyl)Amino)-N-(5-Substitutedphenyl)- 1,3,4- Thiadiazol-2-Yl)Acetohydrazide And Evaluation of Anticancer Activity
Volume: 14 Issue: 3
Author(s): Byran Gowramma*, Thaggikuppe K. Praveen, Subramanian Gomathy, Rajagopal Kalirajan, Baswan Babu and Nagappan Krishnavenic
Affiliation:
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Jagadguru Sri Shivarathreeswara University, Mysore, Udhagamandalam 643001, Tamil Nadu,India
Keywords: Anticancer activity, 1, 3, 4-thiadiazole, daltons lymphoma ascites (DLA) cell line, 5-flurouracil, in vitro and in vivo screening.
Abstract: Objective: The objective of this study was to synthesize a series of 1,3,4-thiadiazole derivative and evaluate their possible in vitro and in vivo anticancer activity.
Method: Compounds 7a-f have been synthesized by chlorination of 2-[bis(2-hydroxyethyl)amino]-N-[5- substituted phenyl)-1,3,4-thiadiazol-2-yl]acetohydrazide with phosphorous oxychloride and phosphorous pentachloride. Synthesis of the targeted compounds was (7a-f) confirmed through their MP, IR, 1HNMR and mass spectrum studies.
Results: Compounds 7a and 7d showed considerable anticancer activity against Hep-2 cell lines and, therefore, selected for the in vitro studies and DLA cell line for the in vivo studies.
Conclusion: It may be concluded that the presence of nitro and chloro phenyl substituted 1,3,4- thiadiazoles showed significant anticancer activity.
Export Options
About this article
Cite this article as:
Gowramma Byran*, Praveen K. Thaggikuppe, Gomathy Subramanian, Kalirajan Rajagopal, Babu Baswan and Krishnavenic Nagappan, Synthesis of 2-(Bis (2-Chloroethyl)Amino)-N-(5-Substitutedphenyl)- 1,3,4- Thiadiazol-2-Yl)Acetohydrazide And Evaluation of Anticancer Activity, Current Bioactive Compounds 2018; 14 (3) . https://dx.doi.org/10.2174/1573407213666170428110528
DOI https://dx.doi.org/10.2174/1573407213666170428110528 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Biochemical Parameters and Vitamin D Levels in ICU Patients with
Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Pro-Oxidant Milieu Blunts Scissors: Insight into Tumor Progression, Drug Resistance, and Novel Druggable Targets
Current Pharmaceutical Design Pharmacological Therapy of Pericardial Diseases
Current Pharmaceutical Design PI3K Pathway Inhibitors: Better Not Left Alone
Current Pharmaceutical Design Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
Current Medicinal Chemistry Controlled Gene Delivery Can Enhance Therapeutic Outcome for Cancer Immune Therapy for Melanoma
Current Gene Therapy Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds
Anti-Cancer Agents in Medicinal Chemistry Studies of p53 Tumor Suppression Activity in Mouse Models
Current Genomics Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates
Current Medicinal Chemistry Advances in Sickle Cell Disease Treatments
Current Medicinal Chemistry Epigenetic Modifications as Therapeutic Targets
Current Drug Targets KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions
Current Genomics Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Current Medicinal Chemistry Hyperpolarized 13Carbon MR
Current Pharmaceutical Biotechnology Novel Insights in Molecular Mechanisms of CLL
Current Pharmaceutical Design Doxycycline as Potential Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets The Concept of a Green Drug, Curcumin and It ’ s Derivatives as a Model System
Mini-Reviews in Organic Chemistry Transposons for Gene Therapy!
Current Gene Therapy